Buruli ulcer: a new case definition for Victoria.


Journal

Communicable diseases intelligence (2018)
ISSN: 2209-6051
Titre abrégé: Commun Dis Intell (2018)
Pays: Australia
ID NLM: 101735394

Informations de publication

Date de publication:
21 Nov 2020
Historique:
entrez: 22 12 2020
pubmed: 23 12 2020
medline: 6 1 2021
Statut: epublish

Résumé

Laboratory-confirmed infection with Mycobacterium ulcerans is currently notifiable to health departments in several jurisdictions. Accurate surveillance is imperative to understanding current and emerging areas of endemicity and to facilitate research into a neglected tropical disease with poorly-understood transmission dynamics. The state of Victoria currently reports some of the highest numbers of M. ulcerans cases in the world each year, with 340 cases notified in 2018 (an incidence of 5.5 per 100,000 population). In May 2019, a group of clinical, laboratory and public health experts met to discuss a new case definition for the surveillance of M. ulcerans disease in Victoria, incorporating clinical and epidemiological elements. The new case definition supports important public health messaging and actions for residents and visitors to popular tourist areas in Victoria.

Identifiants

pubmed: 33349204
doi: 10.33321/cdi.2020.44.93
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Commonwealth of Australia CC BY-NC-ND.

Auteurs

Juliana M Betts (JM)

Victorian Government Department of Health and Human Services.
School of Public Health and Preventive Medicine, Monash University, Melbourne.

Ee Laine Tay (EL)

Victorian Government Department of Health and Human Services.

Paul D R Johnson (PDR)

Department of Infectious Diseases, Austin Hospital, Melbourne.

Caroline J Lavender (CJ)

Mycobacterium Reference Laboratory, Victorian Infectious Diseases Reference Laboratory (VIDRL), at the Peter Doherty Institute for Infection and Immunity, Victoria, 3000, Australia.

Katherine B Gibney (KB)

Victorian Government Department of Health and Human Services.
Department of Infectious Diseases, Austin Hospital, Melbourne.
The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, 3000, Australia.

Daniel P O'Brien (DP)

Department of Infectious Diseases, University Hospital, Geelong.
Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne.

Maria Globan (M)

Mycobacterium Reference Laboratory, Victorian Infectious Diseases Reference Laboratory (VIDRL), at the Peter Doherty Institute for Infection and Immunity, Victoria, 3000, Australia.

Nectaria Tzimourtas (N)

Victorian Government Department of Health and Human Services.

Miriam A O'Hara (MA)

Victorian Government Department of Health and Human Services.

Simon R Crouch (SR)

Victorian Government Department of Health and Human Services.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH